CYP24A1 and cancer: Realisation of such an approach would require synthesis of a library of fragment-like sulfamides and profiling them against a panel of human CAs (in this case, anti-glaucoma target hCA II, two membrane-associated cancer-related targets hCA IX and XII and the usual cytosolic off-target hCA I).